tarspro
Posted - 23 hours ago
@Torp Or maybe $BAX?? Few others out there.
ICUMaximGroupshortingICU
Posted - 2 days ago
$BAX yo you guys please buy $ICU , we tired
Torp
Posted - 2 days ago
$ICU a lot of volume today for $BAX
Youngandhappy
Posted - 3 days ago
@WWladSMT @vitoi @KSTom No sell, no loss. Add! Thenadd! $BAX merger approacheth! MB
Youngandhappy
Posted - 4 days ago
@Codexxx The $BAX spin off makes the most sense here XXX. Schlorff and team are too long in the tooth to simply sit back while we plummet to the center of the earth without a plan near and dear to our hearts which takes this miraculous cure to the masses as quickly as possible. MB
Youngandhappy
Posted - 4 days ago
$ICU $NUWE $FMS $DVA $BAX CMO Dr. Kevin is a winner. Quelimmune SCD is a winner. The planet will soon be the biggest winner because of that combination. MB
Aigner_Andreas
Posted - 1 week ago
TF SELL $BAX at 39.57 : 39.61 BigCap 98% Shp 1.42 S 1.94 N 0.89 RSI 33.34% SRSI 0% ADXR 29.44 #stocks #trading #finance #market
FutureOpt
Posted - 1 week ago
$BAX $FMS $ICU They are giving us all the tips regarding a merger or a buyout. I was just about to post this 👇
Also check page 48
Load the boat!
SideJobTrader
Posted - 1 week ago
$ICU They didn't have to mention $FMS $BAX but they did? #MB
Ricothetweko
Posted - 1 week ago
$BAX Only .08cents from touching the 200sma on the daily chart. Looking for a bounce here back to 50sma. Stand By.
Julian46
Posted - 1 week ago
$ICU $BAX
11thestate
Posted - 1 week ago
$BAX Even if the deadline has passed you can still file for a late claim
Youngandhappy
Posted - 1 week ago
@Profitfire @Nmd_1980 $BAX, and how exactly are they involved in anything here. The sale of their Kidney business in July? To whom? They still own the spinoff, do they not? Davita buys it? Fresenius buys it? Please explain your hunches. TY. $NUWE $ICU MB, NS, MP
Stock_Titan
Posted - 2 weeks ago
$BAX Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
https://www.stocktitan.net/news/BAX/baxter-expands-pharmaceuticals-portfolio-with-new-injectable-7jxpbhr5msdu.html
Profitfire
Posted - 2 weeks ago
$NUWE $ICU $DVA and $BAX there is something coming 🌚 who will merge with nuwe ?! I expecting a 100% merger run from this level with NUWE Remember with low volume trading a stock is falling… will recover fast with value trading 😏📈 patent news data updates are still good here some day we will turn up fast again 🙌
Stock_Titan
Posted - 2 weeks ago
$BAX Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors
https://www.stocktitan.net/news/BAX/baxter-to-host-first-quarter-2024-financial-results-conference-call-vykvbpeddww5.html
ICUMaximGroupshortingICU
Posted - 3 weeks ago
$BAX $ICU mb
11thestate
Posted - 3 weeks ago
$BAX pays $18M to investors who suffered losses because of its false statements. Claim submission info and details:https://11thestate.com/cases/baxter-fair-fund Who is eligible to get a payout? All persons who purchased or otherwise acquired shares of Baxter International common stock during the period from May 6, 2015, through October 23, 2019, inclusive.
DonCorleone77
Posted - 3 weeks ago
$BAX FDA clears Baxter's Novum IQ LVP and dose IQ safety software Baxter International announced U.S. Food and Drug Administration FDA 510 k clearance of its Novum IQ large volume infusion pump LVP with Dose IQ Safety Software. Adding LVP modality to the Novum IQ Infusion Platform - which includes Baxter's syringe infusion pump with Dose IQ Safety Software, powered by the IQ Enterprise Connectivity Suite - enables clinicians to utilize a single, integrated system across a variety of patient care settings. Offering the Novum IQ LVP in the U.S. demonstrates Baxter's commitment to continued innovation in advancing infusion therapy. Heather Knight, executive vice president and group president, Medical Products and Therapies at Baxter, highlighted the customer-centric approach of the Novum IQ platform, emphasizing its role in helping to enhance care delivery. "Our goal, always, is to bring increased efficiency, safety and opportunity for informed decision-making to our customers..."
Stock_Titan
Posted - 3 weeks ago
$BAX Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
https://www.stocktitan.net/news/BAX/baxter-announces-u-s-fda-clearance-of-novum-iq-large-volume-infusion-ivdzhhjjd7zq.html
Aznwactrackstar
Posted - 03/29/24
$ICU this is the pic from $BAX site
GoodTidings
Posted - 03/29/24
$ICU $BAX True!!! But from Baxter perspective its the opposite!!!
😃😃😃💪💪💪💸💸💸
steveboehm
Posted - 03/29/24
$ICU $BAX And why would buyout need to happen before spinoff? Personally, I think the longer we can delay buyout the better
John_Wick1234
Posted - 03/29/24
$BAX Rising Support Trendline
GoodTidings
Posted - 03/28/24
$ICU $BAX Maybe that new CEO is Kevin Chung or ICU Current CEO Eric Schlorff?
🤔🤔🤔
GoodTidings
Posted - 03/28/24
$ICU Maybe Yesterday buying Spree has to do with the $BAX strong BO speculation of SeaStar Medical!!!
🤔🤔🤔
GoodTidings
Posted - 03/28/24
$ICU $BAX The latest update on Baxter's kidney reorganization is that the company is moving forward with its restructuring plans and is still on track to spin off its kidney care business into a separate, publicly traded company by July 2024. The new company will be named **Vantive**¹². Baxter is also in the process of finalizing a search for a CEO to lead Vantive¹. Additionally, Baxter has been exploring strategic alternatives for its biopharma solutions unit, which has attracted significant interest¹. The restructuring aims to simplify operations and focus on improving outcomes for patients with kidney disease and other vital organ support through innovative technologies and services².
Bron: Gesprek met Bing, 29-3-2024
(1) Baxter restructures, kidney care spinoff still planned for 2024. https://www.medtechdive.com/news/baxter-q1-earnings-kidney-spinoff-BAX/648794/.
(2) Baxter - Baxter Announces Vantive as the Name of Proposed Kidney Care ....
GoodTidings
Posted - 03/28/24
$ICU $BAX The best time for Baxter to buyout SeaStar Medical is before Adult approval and before July 2024 when the new spinoff company is expected to be sold to the market!!!
Before adult approval would benefit Baxter for buyout price and second it would need to buyout ICU anyways before July 2024 company spinoff and IPO!!!
GoodTidings
Posted - 03/28/24
$ICU $BAX For Baxter to sell a kidney spin off company on the NASDAQ stock exchange to make it a success it should be a complete proposition!!!
ICU with breakthrough SCD device would make it a complete and attractive key sales proposition with a huge edge against any competitor in the market!!!
Sales of $8 billion worth of stock could be a serious indicator of ICU BO preparations and reorganization!!! Hold on to your golden tickets cause interesting events are about to unfold!!!
🤔🤔🤔
GoodTidings
Posted - 03/28/24
$ICU The $BAX BO speculation is quite interesting and not far fetched... All kind of signs that point to serious Baxter interest...
1 - Baxter Sponsorship
2 - Perfect fit on Baxter CRRT device
3 - Inventor of SCD wearing Baxter shirt
4 - Baxter reorganization to spinoff a separate kidney focussed company for IPO on the stock market
5 - Sales of $8 billion worth of stock
🤔🤔🤔